3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Prostatic Neoplasms
5
Neoplasms
3
Carcinoma, Non-Small-Cell Lung
3
Urinary Bladder Neoplasms
2
Lymphoma, Follicular
2
Lung Neoplasms
2
Hematologic Neoplasms
2
Colonic Neoplasms
2
Carcinoma, Neuroendocrine
2
Breast Neoplasms
2
Thyroid Neoplasms
1
Rectal Neoplasms
1
Pancreatic Neoplasms
1
Pancreatic Ductal Adenocarcinoma
1
Neuroendocrine Tumors
1
Neoplastic Cells, Circulating
1
Neoplasms, Plasma Cell
1
Neoplasm Metastasis
1
Myocarditis
1
Multiple Pulmonary Nodules
1
Multiple Myeloma
1
Lymphoma, Non-Hodgkin
1
Lymphoma, B-Cell, Marginal Zone
1
Lymphoma, B-Cell
1
Liver Metastases
1
Liver Malignancy
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Leukemia
1
Intraabdominal Infections
1
Head and Neck Neoplasms
1
Interventions
Temozolomide
101
Radiotherapy
50
Magnetic Resonance Spectroscopy
38
Radiation
28
Specimen Handling
25
pembrolizumab
23
Bevacizumab
23
Lomustine
16
Nivolumab
14
Surgical Procedures, Operative
11
atezolizumab
8
Cyclophosphamide
8
Biopsy
8
abemaciclib
7
Ipilimumab
7
Carboplatin
7
fludarabine
6
Radiotherapy, Intensity-Modulated
6
Aminolevulinic Acid
6
olaparib
5
Metformin
5
Drug Therapy
5
Diet, Ketogenic
5
Dianhydrogalactitol
5
regorafenib
4
poly ICLC
4
cemiplimab
4
Radiosurgery
4
Photons
4
Leukapheresis
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Glioblastoma
×
Positron Emission Tomography Computed Tomography
×
1 year
×
Clear all
No trials found.